文献速递生殖医学

助孕治疗前母亲酒精与咖啡因摄入与辅助生殖结局的前瞻性队列研究

The association between pre-treatment maternal alcohol and caffeine intake and outcomes of assisted reproduction in a prospectively followed cohort.
PubMed 文献 · Hum Reprod · 2017-01-01

该前瞻性队列纳入300名女性(493个辅助生殖周期),评估治疗前一年酒精与咖啡因摄入与辅助生殖结局的关系。低至中等酒精和咖啡因摄入与活产率无显著关联,调整后活产百分比在各摄入类别间趋势检验无统计学意义。

要点

  • 治疗前一年低至中等酒精摄入(如≤12 g/天)与辅助生殖活产率无显著关联(趋势检验 P=0.87)。
  • 治疗前一年低至中等咖啡因摄入(如<200 mg/天)与辅助生殖活产率无显著关联(趋势检验 P=0.34)。
  • 特定酒精和含咖啡因饮料类型与辅助生殖治疗结局均未观察到关联。

核心结论

  • 治疗前一年低至中等酒精和咖啡因摄入与辅助生殖 intermediate 或临床结局无不良影响。

研究设计与样本

  • 环境与生殖健康研究(2006-2016年)前瞻性队列,纳入300名女性共493个辅助生殖周期。
  • 治疗前摄入量通过经验证的食物频率问卷回顾性评估,辅助生殖终点从电子病历提取。
  • 采用广义线性混合模型(随机截距)评估关联,校正年龄、BMI、吸烟状态、不孕诊断、方案类型、种族、饮食模式及热量、维生素B12和叶酸摄入。

主要发现

  • 治疗前酒精摄入中位数(范围)为5.6(0.0-85.8)g/天,咖啡因摄入中位数(范围)为124.9(0.3-642.2)mg/天。
  • 启动周期活产调整百分比(95%CI)按酒精摄入递增类别:不饮酒者34%(20, 52%),0.1-6 g/天46%(36, 57%),6.1-12 g/天41%(29, 53%),12.1-24 g/天42%(31, 55%),>24 g/天41%(22, 63%)(趋势检验 P=0.87)。
  • 启动周期活产调整百分比(95%CI)按咖啡因摄入递增类别:<50 mg/天46%(36-57%),50.1-100 mg/天44%(29, 60%),100.1-200 mg/天42%(31, 53%),200.1-300 mg/天40%(28, 53%),>300 mg/天40%(21, 63%)(趋势检验 P=0.34)。
  • 评估特定类型酒精和含咖啡因饮料时,与辅助生殖治疗结局均未观察到关联。

临床怎么用

  • 作者认为结果提供 reassurance:治疗开始前一年低至中等酒精(如≤12 g/天)和咖啡因(如<200 mg/天)摄入对辅助生殖 intermediate 或临床结局无不良影响。

局限性

  • 由于观察性研究性质,不能排除其他饮食和生活方式因素的残余混杂。
  • 尚不清楚这些结果对未借助辅助生殖自然受孕女性的可推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is pre-treatment alcohol and caffeine intake associated with infertility treatment outcomes among women undergoing ART? SUMMARY ANSWER: Low to moderate alcohol and caffeine intakes in the year prior to infertility treatment were not related to ART outcomes. WHAT IS KNOWN ALREADY: Alcohol and caffeine intake have been found to be associated with infertility in some studies. Nevertheless, data on their relation with outcomes of infertility treatments are scarce and inconsistent. STUDY DESIGN, SIZE, DURATION: We included 300 women (493 ART cycles) from the Environment and Reproductive Health Study, an ongoing cohort study (2006-2016). PARTICIPANTS/MATERIALS, SETTING, METHODS: Pre-treatment intakes of alcohol and caffeine were assessed retrospectively using a validated food frequency questionnaire. Intermediate and clinical endpoints of ART were abstracted from electronic medical records. Generalized linear mixed models with random intercepts to account for multiple ART cycles per woman were used to evaluate the association with ART outcomes adjusting for age, BMI, smoking status, infertility diagnosis, protocol type, race, dietary patterns, and calories, vitamin B12 and folate intake. MAIN RESULTS AND THE ROLE OF CHANCE: Median (range) pre-treatment alcohol and caffeine intakes were 5.6 (0.0-85.8) g/day and 124.9 (0.3-642.2) mg/day, respectively. The adjusted percentage of initiated cycles resulting in live birth (95% CI) for women in increasing categories of pre-treatment alcohol intake was 34% (20, 52%) for non-consumers, 46% (36, 57%) for 0.1-6 g/day, 41% (29, 53%) for 6.1-12 g/day, 42% (31, 55%) for 12.1-24 g/day, and 41% (22, 63%) for >24 g/day (P, trend = 0.87). The adjusted percentage of cycles resulting in live birth (95% CI) for women in increasing categories of caffeine intake was 46% (36-57%) for <50 mg/day, 44% (29, 60%) for 50.1-100 mg/day, 42% (31, 53%) for 100.1-200 mg/day, 40% (28, 53%) for 200.1-300 mg/day and 40% (21, 63%) for >300 mg/day (P, trend = 0.34). When specific types of alcoholic and caffeinated beverages were evaluated, no relations with ART treatment outcomes were observed. LIMITATIONS, REASONS FOR CAUTION: Residual confounding by other diet and lifestyle factors cannot be ruled out owing to the observational nature of this study. It is also unclear how generalizable these results are to women who are conceiving without the assistance of ART. WIDER IMPLICATIONS OF THE FINDINGS: Our results provide reassurance that low to moderate intakes of alcohol (e.g. ≤12 g/day) and caffeine (e.g. <200 mg/day) in the year prior to infertility treatment initiation do not have an adverse effect on intermediate or clinical outcomes of ART. STUDY FUNDING/COMPETING INTEREST(S): The authors are supported by National Institutes of Health (NIH) grants ES022955, R01ES009718, R01ES000002, P30DK46200 and L50-HD085359. No conflicts of interest to declare. TRIAL REGISTRATION NUMBER: NCT00011713.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Abadia L, Chiu YH, Williams PL, et al. The association between pre-treatment maternal alcohol and caffeine intake and outcomes of assisted reproduction in a prospectively followed cohort. Hum Reprod. 2017. PMID: 28854726. doi:10.1093/humrep/dex237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。